Pharmacogenomics (PGx) focuses on how genes and biomarkers can affect how an individual respond to drugs. The goal of PGx is to develop effective, safe medications and doses that can be tailored to an individual's genetic makeup.
Risk Management Services
PRA Health Sciences (PRA) experts have significant experience providing end-to-end risk management services. Our integrated global teams identify…
Optimize drug therapy with respect to the patient’s genotype, ensuring maximum drug efficiency with minimal adverse effects.
Endpoint Adjudication Services
PRA uses a proprietary electronic Endpoint Adjudication Tool that semi-automates many steps in the end-to-end endpoint adjudication workflow. Some of…